logo oncology-news

Онкология  >  Новости онкологии

При финансовой поддержке logo MSD Oncology

Bevacizumab biosimilar gets FDA nod for 5 cancer types

Bevacizumab-bvzr could offer a cheaper alternative to the reference product.